# US 2017/0283762 A1 · Method of isolating probiotics of human intestine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283762 A1
- Document ID: US20170283762A1
- Status: Published application
- Kind: A1
- Application number: 15/510,238
- Filed: 2015-11-23
- Published: 2017-10-05
- Earliest claimed: 2015-10-23
- Assignees: Guangzhou Kangze Medical Technology Co., Ltd.; Zhujiang Hospital, Southern Medical University
- Applicants: Guangzhou Kangze Medical Technology Co., Ltd.; Zhujiang Hospital of Southern Medical University
- Inventors: Yongzheng PENG; Jiangfeng YI; Xianfeng GUO
- Web page: https://patentgrep.com/patent/US20170283762A1

## CPC

- C12N 1/02: Separating microorganisms from their culture media
- C12N 1/20: Bacteria; Culture media therefor
- C12Q 1/68: involving nucleic acids
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method of isolating probiotics of human intestine, including preparing bases for culturing liquid and solid mucoproteins; and filtering, which includes collecting human feces, planting the human feces in the base for culturing liquid mucoprotein, culturing the human feces to obtain microbial liquid, using the microbial liquid as template, pouring the microbial liquid into tubes, subjecting the tubes to a PCR test, selecting the tubes tested positive in the PCR test, pouring the microbial liquid in the positive tubes into the base for culturing solid mucoprotein, culturing the microbial liquid to obtain first colonies, planting the colonies in a chocolate tablet, culturing the first colonies to obtain second colonies, planting the second colonies in a Columbia blood tablet, purifying the second colonies to obtain third colonies, using 16sRNA common primers to identify the third colonies in the PCR, and isolating probiotics.

## Claims

### Claim 1

A method of isolating probiotics of human intestine comprising the following steps:
Step 1: preparing culture bases, including preparing a base for culturing liquid mucoprotein and preparing a base for culturing solid mucoprotein; and
Step 2: filtering, including collecting human feces samples, planting the human feces samples in the base for culturing liquid mucoprotein, culturing the human feces samples in an anaerobic environment to obtain microbial liquid, using the microbial liquid as template for PCR test which comprises pouring the microbial liquid into tubes and subjecting the tubes to PCR test, selecting the tubes tested positive in the PCR test, planting the microbial liquid in the tubes tested positive on the base for culturing solid mucoprotein, culturing the microbial liquid on the base for culturing solid mucoprotein in an anaerobic environment to obtain first colonies, planting the first colonies in a chocolate tablet, culturing the first colonies in an anaerobic environment to obtain second colonies, planting the second colonies in a Columbia blood tablet, purifying the second colonies in an anaerobic environment to obtain third colonies, using 16sRNA common primers to identify the third colonies in PCR sequence identification, and isolating probiotics of human intestine.

### Claim 2 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the mucoprotein in both the base for culturing solid mucoprotein and the base for culturing liquid mucoprotein is purified mucoprotein.

### Claim 3 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the primers used in the PCR test are primer 1 having the sequence of SECS ID NO: 1 (CAGCACGTGAAGGTGGGGAC), and primer 2 having the sequence SEQ ID NO: 2 (CCTTGCGGTTGGCTTCAGAT).

### Claim 4 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the human feces samples are planted on the base for culturing liquid mucoprotein for culturing in the anaerobic environment at 37° C. for four days.

### Claim 5 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the microbial liquid is planted on the base for culturing solid mucoprotein for culturing in the anaerobic environment at 37° C. for three days.

### Claim 6 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the first colonies are planted on the chocolate tablet for culturing in the anaerobic environment at 37° C. for two days.

### Claim 7 (depends on 1)

The method of isolating probiotics of human intestine as in claim 1, wherein the planting of the second colonies in the Columbia blood tablet for purification is repeated three times, wherein in each time, purification temperature is set at 37° C. and lasts for five days.

### Claim 8 (depends on 2)

The method of isolating probiotics of human intestine as in claim 2, wherein purification of the mucoprotein comprises the following steps:
Preparing reagents:
Ethanol without water (cooled at 4° C.);
Solution A: 0.2 g of NaH2PO4 without water, 7 g of Na2HPO4·12H2O, 6 g of NaCL, pH adjusted to 7.8, constant volume being adjusted to 1,000 ml, kept at high pressure and 125° C. for 30 mins, and subsequently kept at room temperature;
Solution B: 5.85 g of NaCL, pH adjusted to 7.0, constant volume being adjusted to 1,000 ml, and kept at high pressure and 125° C. for 30 mins; and subsequently kept at room temperature;
adding 10-15 g of mucoprotein powder to a reagent bottle containing 500 ml of solution A to form a solution; agitating the solution evenly by a magnetic agitator for 2 hours; adding 1M sodium hydroxide to the solution to adjust pH value to 7.2±0.2; adding 500-1,000 μl of toluene to the solution; agitating the solution evenly by the magnetic agitator for 18 hours; subjecting the solution to rotation by a centrifugal device rotating at 3,000 rpm for 10 mins; collecting liquid upper portion of the solution and transferring the liquid upper portion of the solution to a second reagent bottle which has been subjected to high pressure, discarding deposited residue of the solution; adding cooled ethanol without water to the liquid upper portion in the second reagent bottle to reach a concentration percentage of about 60%; placing the second reagent bottle in a refrigerator and kept at 4° C. for 30 mins; subjecting the second reagent bottle to rotation by the centrifugal device rotating at 3,000 rpm for 10 mins to obtain a second liquid upper portion and a second deposited residue; discarding the second liquid upper portion and collecting the second deposited residue; dissolving the second deposited residue in 200 ml of the solution B, and then agitating for 6 hours, and after that subjecting the solution B to rotation by the centrifugal device rotating at 3,000 rpm for 10 mins to obtain a third liquid upper portion and a third deposited residue; transferring the third liquid upper portion to a third reagent bottle which has been subjected to high pressure, and discarding the third deposited residue;
adding cooled ethanol without water to the third liquid upper portion in the third reagent bottle to reach a concentration percentage of about 60%; placing the third reagent bottle in a refrigerator and keeping at 4° C. for 30 mins; subjecting the third reagent bottle to rotation by the centrifugal device rotating at 3,000 rpm for 10 mins to obtain a fourth liquid upper portion and a fourth deposited residue;
discarding the fourth liquid upper portion and collecting the fourth deposited residue; dissolving the fourth deposited residue in 100 ml of distilled water and keeping in a sealed condition at 4° C.

### Claim 9 (depends on 2)

The method of isolating probiotics of human intestine as in claim 2, wherein the base for culturing liquid mucoprotein is prepared as follows:
Preparing reagents:
Acid chemical compounds, including 1.491 g of FeCL2·4H2O, 0.06 g of H3BO4, 0.068 g of ZnCL2, 0.1725 g of CuCL2·7H2O, 0.0635 g of MnCL2, 0.0119 g of CoCL2·6H2O, 0.0235 g of NiCL2·6H2O, 4.18 ml of HCL, and the rest being distilled water to make up a constant volume of 100 ml;
Basic chemical compounds, including 0.01729 g of Na2SeO3, 0.0242 g of Na2MoO4·2H2O, 0.4 g of NaOH, and the rest being distilled water to make up a constant volume of 100 ml;
Liquid vitamin, including 0.02 g of biotin, 0.21 g of Vit B3, 0.5 g of Vit B2, 0.1 g of Vit B2, 0.2 g of Bit B1, 0.25g of Vit B12, 0.1 g of pantothenic acid, and the rest being, distilled water to make up a constant volume of 100 ml;
Solution 1, including 1.1 g of CaCL2, 1.0 g of MgCL2, 1 ml of the acid chemical compounds, 1 ml of the basic chemical compounds, and the rest being distilled water to make up a constant volume of 100 ml; said solution 1 is kept at high pressure and 125° C. for 30 mins, and is subsequently kept at room temperature in a sealed condition;
Solution 2, including 5.3 g of Na2HPO4, 3 g of NaCL, 4 g of KH2PO4, and the rest being distilled water to make up a constant volume of 100 ml; said solution 2 is kept at high pressure and 125° C. for 30 mins, and is subsequently kept at room temperature in a sealed condition;
Solution 3, including 2 g of NaHCO2, 2 ml of the liquid vitamin, constant volume being adjusted to 100 ml, filtered, by a 0.22 μm filter, and is subsequently kept at 4° C. in a sealed condition;
Solution 4, including 2.5 g of Na2S and the rest being distilled water to makeup a constant volume of 100 ml, filtered by a 0.22 μm filter, and is subsequently kept at 4° C. in a sealed condition;
Adding 200 ml of sterilized distilled water to a beaker that has been subjected to high pressure, sequentially adding 2 ml of solution 1, 2 ml of solution 2, 1 ml of solution 3. 2 ml of solution 4 and 30-40 ml of purified mucoprotein solution to the beaker on a clean bench to form a liquid mixture, wherein the beaker is shaken, evenly after each adding step, sucking 5 ml of the liquid mixture by means of an electric liquid suction device and adding 5 ml of the liquid mixture to each of a plurality of tubes having 15ml volume, sealing the tubes and keeping the tubes at 4° C. in a sealed condition

### Claim 10 (depends on 2)

The method of isolating probiotics of human intestine as in claim 2, wherein the base for culturing solid mucoprotein is prepared as follow:
Preparing reagents:
Acid chemical compounds, including 1.491 g of FeCL2·4H2O, 0.06 g of H3BO4, 0.068 b of ZnCL2, 0.1725 g of CuCL2·7H2O, 0.0635 g of MnCL2, 0.0119 g of CoCL2·6H2O, 0.0235 g of NiCL2·6H2O, 4.18 ml of HCL, and the rest being distilled water to make up a constant volume of 100 ml;
Basic chemical compounds, including 0.017299 g of Na2SeO3, 0.242 g of Na2MoO4·2H2O, 0.4 g of NaOH, and the rest being distilled water to make up a constant volume of 100 ml;
Liquid vitamin, including 0.02 g of biotin, 0.21 g of Vit B3, 0.5 g of Vit B6, 0.1 g of Vit B2, 0.2 g of Vit B1, 0.5 g of Vit B12, 0.1 g of pantothenic acid, and the rest being distilled water to make up a constant volume of 100 ml;
Solution 1, including 1.1 g of CaCL2, 1.0 g of MgCL2, 1 ml of the acid chemical compounds, 1 ml of the basic chemical compounds, and the rest being distilled water to make up a constant volume of 100 ml; said solution 1 is kept at high pressure and 125° C. for 30 mins and is subsequently kept at room temperature in a sealed condition.
Solution 2, including 5.3 g of Na2HPO4, 3 g of NaCL, 4 g of KH2PO4, and the rest being distilled water to make up a constant volume of 100 ml; said solution 2 is kept at high pressure and 125° C. for 30 mins, and is subsequently kept at room temperature in a sealed condition;
Solution 3, including 2 g of NaHCO3, 2 ml of the liquid vitamin constant volume being adjusted to 100 ml, filtered by a 0.22 μm filter, and is subsequently kept at 4° C. in a sealed condition;
Solution 4, including 2.5 g of Na2S and the rest being distilled water to make up a constant volume of 100 ml filtered by a 0.22 μm filter, and is subsequently kept at 4° C. in a sealed condition;
Adding 2 g of agar (sold by OXIOD, United Kingdom) to 200 ml of distilled water in a beaker, keeping the beaker at high pressure under 125° C. for 30 mins, after that immediately adding 2 ml of solution 1, 2 ml of solution 2, 1 ml of solution 3, 2 ml of solution 4 and 30-40 ml of purified mucoprotein solution sequentially to the beaker on a clean bench to form a liquid mixture, wherein the beaker is shaken evenly after each adding step, pouring the liquid mixture into a plurality of pasteurized trays each having a capacity of 20 ml, after cooling and solidifying processes, wrapping and sealing each tray in a pasteurized bag, and keeping the trays at 4 ° C. in a sealed condition.
